Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hepatic failure
ADR ID BADD_A02001
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.03      Hepatic failure and associated disorders
09.01.03.002      Hepatic failure
Description A disorder characterized by the inability of the liver to metabolize chemicals in the body. Laboratory test results reveal abnormal plasma levels of ammonia, bilirubin, lactic dehydrogenase, alkaline phosphatase, aminotransferase, and/or prolongation of prothrombin time (INR.) Drug-induced liever injury (DILI) as defined by Hy's Law. [CTCAE] Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed) [MeSH]
MedDRA Code 10019663
MeSH ID D017093; D048550
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Failure liver | Hepatic failure | Liver failure | Hepatic insufficiency | Hepatobiliary insufficiency | Hepatic decompensation | Liver Failure | Hepatic Failure
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01501Moxifloxacin--
BADD_D01502Moxifloxacin hydrochloride--
BADD_D01507Mycophenolate mofetil--
BADD_D01511Nabumetone--
BADD_D01515Nafcillin0.000049%
BADD_D01533Naproxen--
BADD_D01534Naproxen sodium--
BADD_D01546Nefazodone--
BADD_D01547Nefazodone hydrochloride--
BADD_D01557Nevirapine0.002652%
BADD_D01558Nexium--
BADD_D01564Nicotine0.000940%
BADD_D01572Nitisinone0.043124%
BADD_D01576Nitrofurantoin--
BADD_D01587Norfloxacin--
BADD_D01592Obeticholic acid0.005734%
BADD_D01598Ofloxacin--
BADD_D01599Olanzapine--
BADD_D01601Olaparib0.000448%
BADD_D01607Olsalazine--
BADD_D01614Omeprazole--
BADD_D01615Omeprazole magnesium--
BADD_D01617Ondansetron--
BADD_D01618Ondansetron hydrochloride--
BADD_D01624Orlistat0.014138%
BADD_D01627Oseltamivir--
BADD_D01629Osimertinib0.000504%
BADD_D01633Oxaliplatin0.001030%
BADD_D01635Oxaprozin--
BADD_D01653Paclitaxel0.001399%
The 9th Page    First    Pre   9 10 11 12 13    Next   Last    Total 14 Pages